Acadia Healthcare Company, Inc.

ACHC trades with a staggering 40.07% short interest—nearly two-fifths of the float—while sitting 54 RSI points away from overbought territory, suggesting room for upward movement before meaningful resistance emerges. The absence of a P/E ratio signals either unprofitability or data limitations, which warrants caution. With a $2.4B market cap and a 40% short position, any positive catalyst or earnings surprise could ignite a sharp squeeze, though the company's current positioning below its 52-week high indicates prior enthusiasm has cooled. The elevated short ratio combined with neutral momentum creates a precarious setup where technical breakouts could face violent covering rather than sustainable fundamentals-driven gains.